欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0135/001
药品名称Amoxin comp 875 mg / 125 mg
活性成分
    • Amoxicillin trihydrate 875.0 mg
    • Clavulanic acid 125.0 mg
剂型Film-coated tablet
上市许可持有人Ratiopharm Oy PL 67 02631 ESPOO Finland Splitting procedure: New splitted procedure number is IS/H/294/01
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Portugal (PT)
    • Germany (DE)
    • Austria (AT)
      AmoxiPlus "ratiopharm" 1g - Filmtabletten
许可日期2001/05/29
最近更新日期2024/11/18
药物ATC编码
    • J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS
    • J01CR02 amoxicillin and beta-lactamase inhibitor
    • J ANTIINFECTIVES FOR SYSTEMIC USE
    • J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
    • J01 ANTIBACTERIALS FOR SYSTEMIC USE
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Article 4.8(a)(iii), first paragraph
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase